Visiox Pharmaceuticals, Inc. is a privately funded biopharmaceutical company dedicated to the development and commercialization of ophthalmic therapeutic candidates to address prevalent diseases in need of new treatment options. With a focus on disrupting and revolutionizing the current market, Visiox is committed to maximizing patient and physician satisfaction.